Tweenvest Stocks

Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE: 600381)

Health Care · Pharmaceuticals · CN

CN¥4.94

+12.02% today · +7.9% 1Y

Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE: 600381) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $420.60M and employs 134 people.

Over the last twelve months the share price has gained 7.9%, trading between 2.48 and 5.90.

Tweenvest scores Qinghai Spring Medicinal Resources Technology Co., Ltd. across four factors: quality 61/100, value 82/100, growth 98/100. Its strongest factor is growth.

600381 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$420.60M
Revenue (TTM)
$44.03M
P/E
EPS
-0.12
Dividend yield
Beta (5Y)
0.66
52-week high
CN¥5.90
52-week low
CN¥2.48
Avg volume (3M)
Shares outstanding
572.36M
Employees
134
Next earnings

About Qinghai Spring Medicinal Resources Technology Co., Ltd.

Qinghai Spring Medicinal Resources Technology Co., Ltd. specializes in the research, development, and commercialization of cordyceps products. Its operations further extend to the distribution of beverages and aquatic items, providing advertising solutions, and conducting foreign investment activities. The company was established in 2003 and is headquartered in Xining, China.

ISIN
CNE0000017W0
Founded
1998
Listed since
May 8, 2001
Exchange
Shanghai Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.10T$1,226.58-0.57%
Johnson & JohnsonNYSE: JNJ$658.24B$271.58-0.57%
Merck & Co., Inc.NYSE: MRK$385.99B$153.68-1.77%
Roche Holding AGSWX: ROP$371.62BCHF369.70-1.10%
Novartis AGSWX: NOVN$303.81BCHF128.34+1.25%
AstraZeneca PLCLSE: AZN$263.84B£122.92-1.47%
Novo Nordisk A/SCPSE: NOVO B$212.51BDkr307.80+2.86%
Pfizer Inc.NYSE: PFE$162.84B$28.35-0.77%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.